Company Filing History:
1 out of 266 
1 out of 5,081 
1 out of 42 Years Active: 2012
Title: Constance Chollet: Innovator in Anticancer Therapy
Introduction
Constance Chollet is a notable inventor based in Montrouge, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer therapies. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to improving cancer treatment options.
Latest Patents
Chollet holds a patent for "Dimeric derivatives of artemisinin and application in anticancer therapy." This invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin, which can be used in treating cancer. The patent also covers the preparation method of these derivatives and their pharmaceutically acceptable salts. This advancement represents a promising avenue for cancer therapy, potentially improving treatment outcomes for patients.
Career Highlights
Throughout her career, Constance Chollet has worked with esteemed organizations such as Pierre Fabre Medicament and the Centre National de la Recherche Scientifique. Her roles in these institutions have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in medicinal chemistry.
Collaborations
Chollet has collaborated with notable colleagues, including Jean-Pierre Begue and Danielle Bonnet-Delpon. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Constance Chollet's innovative contributions to anticancer therapy highlight her role as a leading inventor in the field. Her patent on dimeric derivatives of artemisinin demonstrates her commitment to advancing medical science and improving patient care.